A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma

Cultura, C. et al. “A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma.” Journal for ImmunoTherapy of Cancer, Aug. 2023. DOI 10.1136/jitc-2023-006880